<?xml version="1.0" encoding="UTF-8"?>
<ref id="B92">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Williams</surname>
    <given-names>A. E.</given-names>
   </name>
   <name>
    <surname>Edwards</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Humphreys</surname>
    <given-names>I. R.</given-names>
   </name>
   <name>
    <surname>Snelgrove</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Rae</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Rappuoli</surname>
    <given-names>R.</given-names>
   </name>
   <etal/>
  </person-group> (
  <year>2004</year>). 
  <article-title>Innate imprinting by the modified heat-labile toxin of 
   <italic>Escherichia coli</italic> (LTK63) provides generic protection against lung infectious disease.
  </article-title>
  <source>
   <italic>J. Immunol.</italic>
  </source>
  <volume>173</volume>
  <fpage>7435</fpage>â€“
  <lpage>7443</lpage>. 
  <pub-id pub-id-type="doi">10.4049/jimmunol.173.12.7435</pub-id>
  <?supplied-pmid 15585869?>
  <pub-id pub-id-type="pmid">15585869</pub-id>
 </mixed-citation>
</ref>
